<SEC-DOCUMENT>0000950103-22-015982.txt : 20220919
<SEC-HEADER>0000950103-22-015982.hdr.sgml : 20220919
<ACCEPTANCE-DATETIME>20220919172314
ACCESSION NUMBER:		0000950103-22-015982
CONFORMED SUBMISSION TYPE:	424B3
PUBLIC DOCUMENT COUNT:		3
FILED AS OF DATE:		20220919
DATE AS OF CHANGE:		20220919

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Mirion Technologies, Inc.
		CENTRAL INDEX KEY:			0001809987
		STANDARD INDUSTRIAL CLASSIFICATION:	MEASURING & CONTROLLING DEVICES, NEC [3829]
		IRS NUMBER:				830974996
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-260528
		FILM NUMBER:		221251382

	BUSINESS ADDRESS:	
		STREET 1:		1218 MENLO DRIVE
		CITY:			ATLANTA
		STATE:			GA
		ZIP:			30318
		BUSINESS PHONE:		(770) 432-2744

	MAIL ADDRESS:	
		STREET 1:		1218 MENLO DRIVE
		CITY:			ATLANTA
		STATE:			GA
		ZIP:			30318

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	GS Acquisition Holdings Corp II
		DATE OF NAME CHANGE:	20200417
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B3
<SEQUENCE>1
<FILENAME>dp180613_424b3.htm
<DESCRIPTION>FORM 424B3
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Filed Pursuant to Rule 424(b)(3)<BR>
&hairsp;Registration No. 333-260528</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Prospectus Supplement No. 5<BR>
(to prospectus dated March 11, 2022)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><IMG SRC="image_001.jpg" ALT="" STYLE="height: 115px; width: 270px"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 24pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Mirion Technologies, Inc.</P>

<P STYLE="font: bold 24pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Up to 8,560,540 Shares of our Class&nbsp;A
Common Stock Issuable upon Redemption of Shares of IntermediateCo Class&nbsp;B Common Stock<BR>
Up to 27,249,979 Shares of our Class&nbsp;A Common Stock Issuable upon Exercise of Warrants<BR>
143,250,440&nbsp;Shares of our Class&nbsp;A Common Stock for Resale by the Selling Holders</P>

<P STYLE="font: bold 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">This prospectus supplement
is being filed to update and supplement the information contained in the prospectus dated March 11, 2022 (the &ldquo;Prospectus&rdquo;),
which forms part of our registration statement on Form S-1 (No. 333-260528) with the information contained in our Current Report on Form
8-K, filed with the Securities and Exchange Commission (the &ldquo;SEC&rdquo;) on September 19, 2022 (the &ldquo;Current Report&rdquo;).
Accordingly, we have attached the Current Report to this prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt">The Prospectus and this prospectus supplement relate
to: (1)&nbsp;the issuance by us of up to an aggregate of 35,810,519 shares of Class&nbsp;A common stock, par value $0.0001 per share (&ldquo;Class&nbsp;A
common stock&rdquo;), of Mirion Technologies, Inc. (the &ldquo;Company&rdquo;) that may be issued upon (i)&nbsp;the exercise of 27,249,979
warrants to purchase Class&nbsp;A common stock at an exercise price of $11.50 per share of Class&nbsp;A common stock, including the public
warrants and the private placement warrants (each as defined in the Prospectus), and (ii)&nbsp;the redemption of up to 8,560,540 shares
of Class&nbsp;B common stock, par value $0.0001 per share (the &ldquo;IntermediateCo Class&nbsp;B common stock&rdquo;), of Mirion IntermediateCo,
Inc. (&ldquo;IntermediateCo&rdquo;); and (2)&nbsp;the offer and sale, from time to time, by the selling holders identified in the Prospectus
(the &ldquo;Selling Holders&rdquo;), or their permitted transferees, of up to 143,250,440&nbsp;shares of Class&nbsp;A common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt">This prospectus supplement updates and supplements
the information in the Prospectus and is not complete without, and may not be delivered or utilized except in combination with, the Prospectus,
including any amendments or supplements thereto. This prospectus supplement should be read in conjunction with the Prospectus and if there
is any inconsistency between the information in the Prospectus and this prospectus supplement, you should rely on the information in this
prospectus supplement. Terms used in this prospectus supplement but not defined herein shall have the meanings given to such terms in
the Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">You should read the Prospectus, this prospectus
supplement and any additional prospectus supplement or amendment carefully before you invest in our securities. Our Class A common stock
and public warrants are listed on the New York Stock Exchange under the symbols &ldquo;MIR&rdquo; and &ldquo;MIR WS,&rdquo; respectively.
On September 16, 2022, the closing price of our Class A common stock was $7.45 per share and the closing price for our public warrants
was $1.54 per warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt"><B>Investing in our Class A common stock and warrants
involves a high degree of risk. See the section titled &ldquo;Risk Factors&rdquo; beginning on page 19 of the Prospectus and in any applicable
prospectus supplement.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt"><B>Neither the SEC nor any other state securities
commission has approved or disapproved of these securities or passed on the adequacy or accuracy of the Prospectus or this prospectus
supplement. Any representation to the contrary is a criminal offense.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">September 19, 2022</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>UNITED
STATES</B>&nbsp;</FONT></P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>SECURITIES
AND EXCHANGE COMMISSION</B>&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Washington,
D.C. 20549</B></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 3pt auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>FORM
8-K</B></FONT></P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 3pt auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>CURRENT
REPORT </B></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>PURSUANT
TO SECTION 13 OR 15(d) </B></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>OF
THE SECURITIES EXCHANGE ACT OF 1934</B></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Date
of Report (date of earliest event reported): September 13, 2022</B></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 3pt auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 19pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Mirion
Technologies, Inc.</B></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>(Exact
Name of Registrant as Specified in Its Charter)</B></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 3pt auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 12pt; text-align: center; width: 33%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Delaware</B></FONT></TD>
    <TD STYLE="font-size: 12pt; text-align: center; width: 34%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>001-39352</B></FONT></TD>
    <TD STYLE="font-size: 12pt; text-align: center; width: 33%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>83-0974996</B></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 12pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(State
    or Incorporation)</B></FONT></TD>
    <TD STYLE="font-size: 12pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Commission
    File Number)</B></FONT></TD>
    <TD STYLE="font-size: 12pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(I.R.S.
    Employer Identification Number)</B></FONT></TD></TR>
  <TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font-size: 12pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1218
    Menlo Drive</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font-size: 12pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Atlanta,
    Georgia 30318</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font-size: 12pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Address
    of Principal Executive Offices)</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font-size: 12pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(770)
    432-2744</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font-size: 12pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Registrant's
    telephone number, including area code)</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Check the
appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any
of the following provisions:</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: -1.2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;&nbsp;&nbsp;&nbsp;&nbsp;Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: -1.2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: -1.2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;&nbsp;&nbsp;&nbsp;&nbsp;Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: -1.2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: -1.2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;&nbsp;&nbsp;&nbsp;&nbsp;Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: -1.2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: -1.2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;&nbsp;&nbsp;&nbsp;&nbsp;Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: -1.2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: -0.2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Securities
registered pursuant to Section 12(b) of the Act:</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: -0.2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: bottom; font-size: 12pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Title
    of each class</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font-size: 12pt; text-align: center"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Trading</B></FONT></P>
                                                                            <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Symbol(s)</B></FONT></P></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font-size: 12pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name
    of each exchange<BR>
    on which registered</B></FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; border-top: black 1pt solid; font-size: 12pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Class
    A common stock, $0.0001 par value per share</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-top: black 1pt solid; font-size: 12pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>MIR</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-top: black 1pt solid; font-size: 12pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>New
    York Stock Exchange</B></FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; font-size: 12pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Redeemable
    warrants to purchase Class A common stock</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font-size: 12pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>MIR
    WS</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font-size: 12pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>New
    York Stock Exchange</B></FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 19.2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 19.2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&sect;230.405 of this
chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&sect;240.12b-2 of this chapter).</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 19.2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Emerging growth
company &#9744;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">If an emerging
growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any
new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>











<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Item 5.02.
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain
Officers.</B></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Departure
of Christopher Warren from the Board of Directors</I></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 19.2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">On
September 13, 2022, Christopher Warren, a member of the board of directors (the Board) of Mirion Technologies, Inc. (the &ldquo;Company&rdquo;), notified
the Company of his intent to resign from the Board, effective at the close of business on September 16, 2022. Mr. Warren&rsquo;s departure from
the Board is not due to any disagreement with the Company or the Board on any matter relating to the operations, policies or practices
of the Company.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 19.2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Appointment
of Sheila Rege to the Board of Directors</I></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 19.2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">On
September 13, 2022, Christopher Warren, a member of the board of directors (the Board) of Mirion Technologies, Inc. (the &ldquo;Company&rdquo;), notified
the Company of his intent to resign from the Board, effective at the close of business on September 16, 2022. Mr. Warren&rsquo;s departure from
the Board is not due to any disagreement with the Company or the Board on any matter relating to the operations, policies or practices
of the Company.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 19.2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 19.2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">On
September 16, 2022, after recommendation by the Nominating and Corporate Governance Committee of the Board, the Board appointed Ms. Sheila
Rege, M.D., as a member of the Board, effective immediately, to fill the vacancy created by Mr. Warren&rsquo;s resignation. Dr. Rege will stand
for reelection as a member of the Board at the Company&rsquo;s 2023 annual meeting of stockholders. Dr. Rege was also appointed to serve as
a member of the Audit Committee and the Compensation Committee of the Board.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 19.2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 19.2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Dr.
Rege is a board-certified radiation oncologist and the Chief Executive Officer and Founder of Northwest Cancer Clinic, a provider of
radiation oncology and nuclear medicine services, which opened in 2012. Dr. Rege joins the Mirion team with over 30 years of experience
in the field of nuclear medicine and radiation oncology. From 2007 to 2019 Dr. Rege served on the board of directors of Physicians Insurance,
a mutual company, serving as the Chair of the Nominating Committee and a member of the Compensation, Executive and CEO Succession Committee.
Dr. Rege is the recipient of numerous awards and accolades including the American Medical Association Women Physician Section Inspiration
Award in 2021, the Private Company Boardroom &ldquo;2022 Directors to Watch,&rdquo; The American College of Radiation Oncology 2022 Sucha Asbell Mentorship
Award, and has been recognized as a &ldquo;Top Oncologist&rdquo; by Consumer Research Council of America in 2012. Dr. Rege received her B.A. from the
University of California, Berkeley, and her M.D. from the University of California, Los Angeles.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 19.2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 19.2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Dr.
Rege will receive the Company's standard compensation for non-employee directors in accordance with the Company's Non-Employee Director
Compensation Policy, as described in the Company's proxy statement filed with the Securities and Exchange Commission on April 20, 2022.
Dr. Rege will execute an indemnification agreement consistent with the Company&rsquo;s standard form of indemnification agreement, filed as
an exhibit to the Company&rsquo;s Annual Report on Form 10-K for the year ended December 31, 2021.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 19.2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 19.2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">There
is no arrangement or understanding between Dr. Rege and any other persons pursuant to which Dr. Rege was appointed as a director, and,
other than as set forth above, Dr. Rege has no direct or indirect material interest in any transaction required to be disclosed under
Item 404(a) of Regulation S-K.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 19.2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Item 7.01.
Regulation FD Disclosure.</B></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 19.2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">On
September 19, 2022, the Company issued a press release regarding the appointment of Dr. Rege and the departure of Mr. Warren. The full
text of the press release is furnished as Exhibit 99.1 hereto. The information in Exhibit 99.1 hereto is intended to be furnished and
shall not be deemed &ldquo;filed&rdquo; for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section, nor
shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except
as expressly set forth by specific reference in such filing.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 19.2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Item 9.01.
Financial Statements and Exhibits.</B></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>(d) Exhibits</I></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>EXHIBIT
INDEX</B></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 13%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 80%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR>
    <TD COLSPAN="3" STYLE="vertical-align: bottom; font-size: 12pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
    Number</B></FONT></TD>
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="vertical-align: bottom; font-size: 12pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Description</B></FONT></TD></TR>
  <TR>
    <TD COLSPAN="3" STYLE="vertical-align: bottom; border-top: black 1pt solid; font-size: 12pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: blue"><U><A HREF="https://www.sec.gov/Archives/edgar/data/1809987/000162828022025095/a2022-09pressrelease.htm">99.1*</A></U></FONT></TD>
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="vertical-align: bottom; border-top: black 1pt solid; font-size: 12pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: blue"><U><A HREF="https://www.sec.gov/Archives/edgar/data/1809987/000162828022025095/a2022-09pressrelease.htm">Mirion
    Technologies, Inc. press release dated September 19, 2022</A></U></FONT></TD></TR>
  <TR>
    <TD COLSPAN="3" STYLE="vertical-align: bottom; font-size: 12pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</FONT></TD>
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="vertical-align: bottom; font-size: 12pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit
    104 Cover Page Interactive Data File (embedded within the Inline XBRL document)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">* Filed herewith.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>




<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>SIGNATURE</B></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 19.2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 19.2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Date: September
19, 2022</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Mirion
    Technologies, Inc.</B></FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 30%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>/s/ Brian
    Schopfer </U></FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brian Schopfer</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="border-bottom: #D76428 1pt solid; font-size: 12pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 14pt; color: #6D6D6D"><B>News Release</B></FONT></TD>
    <TD STYLE="border-bottom: #D76428 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: #D76428 1pt solid; font-size: 12pt; text-align: right"><IMG SRC="image_003.jpg" ALT="mirion.jpg" STYLE="height: 83px; width: 291px"></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>



<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Mirion Technologies Appoints Dr. Sheila Rege,
M.D. to Board of Directors, Replacing Mr. Christopher Warren</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"><B>Atlanta, GA &ndash; </B>September
19, 2022 &ndash; Mirion Technologies, Inc. (&ldquo;Mirion,&rdquo; &ldquo;we&rdquo; or the &ldquo;Company&rdquo;) (NYSE: MIR), a
global provider of radiation detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and
research end markets, today announced that Dr. Sheila Rege, M.D. has been appointed to the Board of Directors, replacing Mr.
Christopher Warren, who is stepping down.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">Lawrence D. Kingsley, Chairman of Mirion&rsquo;s
Board of Directors said, &ldquo;I am pleased to welcome Sheila to Mirion&rsquo;s Board of Directors. She brings deep experience and a long track record
of accomplishment in nuclear medicine and radiation oncology to Mirion&rsquo;s Board. We are excited to have Sheila join us and believe that
her diverse skill set and voice will be invaluable as Mirion aims to grow its Medical segment to at least 50% of total company revenue
over time.&rdquo;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&ldquo;It is a great honor to have been appointed
to Mirion&rsquo;s Board of Directors,&rdquo; said Dr. Rege. &ldquo;I am a strong believer in Mirion&rsquo;s mission and feel that the Company has strong growth prospects,
especially within the Medical segment. I am excited to begin working alongside my fellow Board members and the management team to contribute
to the Company&rsquo;s future success.&rdquo;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">Dr. Rege is a board-certified radiation
oncologist and the Founder and Chief Executive Officer of Northwest Cancer Clinic, a provider of radiation oncology and nuclear medicine
services, which opened in 2012. Dr. Rege joins Mirion&rsquo;s Board of Directors with over 30 years of experience in the field of nuclear medicine
and radiation oncology. From 2007 to 2019, Dr. Rege sat on the Board of Directors of Physicians Insurance, serving as the Chair of the
Nominating Committee and a member of the Compensation, Executive and CEO Succession Committees. Dr. Rege is the recipient of numerous
awards and accolades including the American Medical Association Women Physician Section Inspiration Award in 2021, the Private Company
Boardroom 2022 &ldquo;Directors to Watch&rdquo;, The American College of Radiation Oncology 2022 Sucha Asbell Mentorship Award, and has been recognized
as a &ldquo;Top Oncologist&rdquo; by the Consumer Research Council of America in 2012. Dr. Rege received her B.A. from the University of California,
Berkeley, and her M.D. from the University of California, Los Angeles.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&ldquo;I would also like to thank Chris Warren
for all of his contributions to Mirion&rsquo;s Board,&rdquo; continued Mr. Kingsley. &ldquo;Chris and the Charterhouse team have been an incredibly supportive
partner, playing a key role in Mirion&rsquo;s growth journey since their initial investment in 2015. We wish Chris all the best in his future
endeavors.&rdquo;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">Chris Warren stated, &ldquo;I leave Mirion&rsquo;s
Board with a great deal of pride in the work we have been able to accomplish together. Since Charterhouse first acquired Mirion in 2015,
the Company has undergone a strategic evolution through the expansion of its Medical segment, while delivering strong growth. I exit
the Board at a point in Mirion&rsquo;s history when the Company is experiencing strong order and demand momentum, supported by healthy and robust
end markets. I believe the Company is in tremendous hands and am excited to see what the team will accomplish in the years to come.&rdquo;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"><B>About Mirion</B></FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">Mirion Technologies is a leading
provider of detection, measurement, analysis and monitoring solutions to the nuclear, defense, medical and research end markets. The
organization aims to harness its unrivaled knowledge of ionizing radiation for the greater good of humanity. Headquartered in
Atlanta (GA &ndash; USA), Mirion employs around 2,800 people and operates in 13 countries. For more information, and for the latest
news and content from Mirion, visit ir.mirion.com.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>
<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="border-bottom: #D76428 1pt solid; font-size: 12pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 14pt; color: #6D6D6D"><B>News Release</B></FONT></TD>
    <TD STYLE="border-bottom: #D76428 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: #D76428 1pt solid; font-size: 12pt; text-align: right"><IMG SRC="image_003.jpg" ALT="mirion.jpg" STYLE="height: 83px; width: 291px"></TD></TR>
</TABLE></P>

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">Contacts:&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"><B>For investor inquiries: </B></FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">Jerry Estes&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">ir@mirion.com</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"><B>For media inquiries: </B></FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">Matthew Maddox&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">mmaddox@mirion.com</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 7; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !S 0X# 2(  A$! Q$!_\0
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MBN8$FA</&XRK#O4E !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MVG,D5Q<A2[2>5YF4RQ)/'U)--N-'MYYY)1+<0^;_ *Y892@DXQSCOCC(P:-
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
64444 %%%% !1110 4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !2 2,# 2(  A$! Q$!_\0
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M-8X;EE74[:ZC$R]/,&U@'']?0_45IRKF4D9*;Y'&1Q*:IJ)0$ZA=_P#?]O\
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84 %%%% !1110 4444 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
